Furuya Lab banner image
FURUYA LABORATORY
Precision cancer prevention & biomarker-driven early detection

We develop and validate non-invasive biomarkers and integrative multi-omics strategies to enable earlier detection, risk stratification, and precision treatment of cancer—with a major focus on bladder cancer and upper-tract urothelial carcinoma.

Urine biomarkers Multiplex protein assays Radiogenomics Spatial biology Clinical translation

PI personal statement

Hideki Furuya
Hideki Furuya, PhD
Translational cancer researcher focused on biomarker-driven precision prevention, early detection, and clinically scalable assay development.

My lab’s goal is to enable precision cancer prevention and earlier, more accurate detection by translating robust biomarker discoveries into practical diagnostic tools. We integrate human cohorts, rigorous analytical validation, and multi-omics biology to connect tissue-level mechanisms with non-invasive biomarkers.

Research focus

  • Urine-based biomarkers for early detection and prognosis
  • Multiplex assay development and analytical validation
  • Radiogenomics and integrative modeling
  • Spatial and multi-omics profiling
Biomarker assay and urine biomarker analysis

Multiplex biomarker assay development and validation.

Spatial biology, imaging, and radiogenomics

Integrating imaging, spatial biology, and multi-omics.